FDA product code PGH: Hsv-1 And Hsv-2 Cns Nucleic-Acid Based Panel

PGH is the FDA product code for hsv-1 and hsv-2 cns nucleic-acid based panel. It is a Class II device, regulated under 21 CFR 866.3307 and reviewed by the Microbiology panel. FDA has cleared 2 510(k) submissions under PGH, 1 in the last five years, from 2 different applicants. The average 510(k) review took 146 days (median 146); 263 days on average over the last three years. 1 De Novo request was granted under it. FDA has posted 1 recall for PGH devices.

Definition

Intended for the qualitative detection and differentiation of HSV-1 and HSV-2 in cerebrospinal fluid (CSF) from patients with signs and symptoms of Herpes Simplex Virus (HSV) central nervous system (CNS) infection. This test is an aid in the diagnosis of HSV-1 and HSV-2 CNS infections in conjunction with other clinical and laboratory findings. Negative results do not preclude HSV-1 or HSV-2 infection and should not be used as the sole basis for treatment or other patient management decisions.

Classification

FieldValue
Device nameHsv-1 And Hsv-2 Cns Nucleic-Acid Based Panel
Device classClass II
Regulation21 CFR 866.3307
Review panelMI — Microbiology
Medical specialtyMicrobiology
Premarket route510(k)
Life-sustaining or supportingYes

510(k) clearances per year for PGH

YearClearancesAvg. review days
20251263

Compare with all 510(k) review times · Search every PGH clearance

Top PGH applicants

ApplicantClearancesLatest
Midiagnostics NV12025-09-30
Focus Diagnostics12014-07-01

Most recent PGH clearances

510(k)ApplicantDeviceDecision dateReview days
K250050Midiagnostics NVmiDiagnostics HSV-1&2 CSF Test2025-09-30263
K141458Focus DiagnosticsSIMPLEXA HSV 1&2 DIRECT/POSITIVE CONTROL PACK2014-07-0129

Recalls for PGH devices

1 product recalls in 1 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2016-02-10.

Frequently asked questions

What is FDA product code PGH?

PGH is the FDA product code for hsv-1 and hsv-2 cns nucleic-acid based panel. It is a Class II device, regulated under 21 CFR 866.3307 and reviewed by the Microbiology panel.

What device class is PGH?

Class II, regulation 21 CFR 866.3307. Typical premarket route: 510(k).

How long does a 510(k) take for product code PGH?

Across 2 cleared submissions the average was 146 days from receipt to decision (median 146).

Which companies have the most PGH clearances?

Midiagnostics NV (1); Focus Diagnostics (1).

Have PGH devices been recalled?

Yes: 1 product recalls across 1 recall events; the most recent began 2016-02-10.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times